{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:19:07Z","timestamp":1783937947394,"version":"3.55.0"},"reference-count":27,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.1080\/14737167.2026.2691179","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:03:47Z","timestamp":1782108227000},"page":"709-721","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Standardizing economic evaluation in Spain\u2019s pharmaceutical pricing and reimbursement system: specification, interpretation and integration"],"prefix":"10.1080","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9233-1776","authenticated-orcid":false,"given":"Marta","family":"Trapero-Bertran","sequence":"first","affiliation":[{"name":"Universitat de Lleida","place":["Igualada, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"e_1_3_6_3_1","volume-title":"Health system efficiency: how to make measurement matter for policy and management","author":"Thomas R","year":"2016","unstructured":"Thomas R, Chalkidou K. Cost-effectiveness analysis. In: Cylus J, Papanicolas I, Smith PC, editors. Health system efficiency: how to make measurement matter for policy and management. Copenhagen: European Observatory on Health Systems and Policies; 2016."},{"key":"e_1_3_6_4_1","unstructured":"National Institute for Health and Clinical Excellence (NICE). NICE technology appraisal and highly specialised technologies guidance: the manual [Internet]. London: NICE; 2025 [cited 2025 Nov 25]. Available from: https:\/\/www.nice.org.uk\/process\/pmg36"},{"key":"e_1_3_6_5_1","volume-title":"Guidelines for the economic evaluation of health technologies: canada","author":"Canadian Agency for Drugs and Technologies in Health (CADTH)","year":"2017","unstructured":"Canadian Agency for Drugs and Technologies in Health (CADTH). Guidelines for the economic evaluation of health technologies: canada. 4th ed. Ottawa: CADTH; 2017 [cited 2025 Nov 25]. Available from: https:\/\/www.cda-amc.ca\/sites\/default\/files\/pdf\/guidelines_for_the_economic_evaluation_of_health_technologies_canada_4th_ed.pdf","edition":"4"},{"key":"e_1_3_6_6_1","unstructured":"Pharmaceutical Benefits Advisory Committee (PBAC). Procedure guidance for listing medicines on the pharmaceutical Benefits Scheme [Internet]. Canberra: Department of Health and Aged Care; 2016 [cited 2025 Nov 26]. Available from:https:\/\/www.pbs.gov.au\/industry\/listing\/procedure-guidance\/files\/Procedure-guidance-for-listing-medicines-on-the-Pharmaceutical-Benefits-Scheme-v2.6.pdf"},{"key":"e_1_3_6_7_1","unstructured":"Health Information and Quality Authority (HIQA). A guide to Health Technology assessment at HIQA [Internet]. Dublin: HIQA; 2016 [cited 2025 Feb 26]. Available from:https:\/\/www.hiqa.ie\/sites\/default\/files\/2017-01\/A-Guide-to-Health-Technology-Assessment.pdf"},{"key":"e_1_3_6_8_1","unstructured":"Perelman J Soares M Mateus C et al. Methodological guidelines for economic evaluation studies. Lisbon: INFARMED; 2019 [cited 2026 Feb 24]. Available from: https:\/\/www.infarmed.pt\/documents\/15786\/4001413\/Orienta%C3%A7%C3%B5es+metodol%C3%B3gicas+para+estudos+de+avalia%C3%A7%C3%A3o+econ%C3B3mica+de+tecnologias+de+sa%C3%BAde+%28EN%29\/ebcfd930-94e2-c7e1100a-ee1df3d76882"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.11.1351"},{"key":"e_1_3_6_10_1","volume-title":"JBI reviewer\u2019s manual [Internet]","author":"Joanna Briggs Institute","year":"2020","unstructured":"Joanna Briggs Institute. JBI reviewer\u2019s manual [Internet]. Adelaide: JBI; 2020 [cited 2025 Nov 25]."},{"key":"e_1_3_6_11_1","volume-title":"Checklist for economic evaluations: critical appraisal tools for use in JBI systematic reviews [Internet]","author":"Joanna Briggs Institute","year":"2020","unstructured":"Joanna Briggs Institute. Checklist for economic evaluations: critical appraisal tools for use in JBI systematic reviews [Internet]. Adelaide: JBI; 2020 [cited 2025 Nov 25]."},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.06.012"},{"key":"e_1_3_6_13_1","unstructured":"Spanish Ministry of Health. Creaci\u00f3n del Comit\u00e9 Asesor para la Financiaci\u00f3n de la Prestaci\u00f3n Farmac\u00e9utica del SNS [Internet]. Madrid: Gobierno de Espa\u00f1a; 2019 [cited 2025 Nov 25]. Available from: https:\/\/www.sanidad.gob.es\/areas\/farmacia\/comitesAdscritos\/prestacionFarmaceutica\/docs\/20190322_Dilig_ACM_Com_Ases_PF_SNS.pdf"},{"key":"e_1_3_6_14_1","unstructured":"Committee for the financing of the pharmaceutical benefit of the Spanish national Health system (CAPF). Recomendaciones sobre los criterios y procedimiento para orientar la fijaci\u00f3n de precios [Internet]. Madrid: Ministerio de Sanidad; 2022 [cited 2025 Nov 25]. Available from: https:\/\/www.sanidad.gob.es\/areas\/farmacia\/comitesAdscritos\/prestacionFarmaceutica\/docs\/20220615_Recoms_Finales_LE2_1LE2_2_CAPF_v15.pdf"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gaceta.2024.102439"},{"key":"e_1_3_6_16_1","unstructured":"Spanish Ministry of Health. Anteproyecto de Ley de los Medicamentos y Productos Sanitarios [Internet]. Madrid: Gobierno de Espa\u00f1a; 2025 [cited 2025 Nov 25]. Available from: https:\/\/www.sanidad.gob.es\/areas\/farmacia\/legislacion\/docs\/Anteproyecto_de_Ley_Medicamento.pdf"},{"key":"e_1_3_6_17_1","unstructured":"Spanish Ministry of Health. Proyecto de Real Decreto por el que se regula la evaluaci\u00f3n de tecnolog\u00edas sanitarias [Internet]. Madrid: Ministerio de Sanidad; 2025 [cited 2025 Nov 25]. Available from: https:\/\/www.sanidad.gob.es\/normativa\/audiencia\/docs\/DG_54_24_Solicitud_informacion_publica_RD_EVALUACION_TECNOLOGIAS_SANITARIAS.pdf"},{"key":"e_1_3_6_18_1","unstructured":"Spanish Ministry of Health. Borrador de Real Decreto sobre precio y financiaci\u00f3n de productos farmac\u00e9uticos y sanitarios [Internet]. Madrid: Gobierno de Espa\u00f1a; 2025 [cited 2025 Nov 25]. Available from: https:\/\/www.sanidad.gob.es\/normativa\/audiencia\/docs\/TEXTO_Y_MAIN_RD_FINANCIACION_PPSS_PARA_IP_Y_TA.pdf"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gaceta.2025.102448"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1744133124000264"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7459.224"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta19140"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200119110-00004"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.2165\/11533000-000000000-00000"},{"issue":"10","key":"e_1_3_6_25_1","first-page":"2327","article-title":"Evidence-informed deliberative processes for health benefit package design - part II: a practical Guide","volume":"11","author":"Oortwijn W","year":"2022","unstructured":"Oortwijn W, Jansen M, Baltussen R. Evidence-informed deliberative processes for health benefit package design - part II: a practical Guide. Int J Health Policy Manag. 2022;11(10):2327\u20132336.","journal-title":"Int J Health Policy Manag"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.12.010"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-020-01160-5"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.02.006"},{"key":"e_1_3_6_29_1","article-title":"La AEMPS ya trabaja en los cuatro escenarios de evaluaci\u00f3n posibles en 2025 y 2026","author":"Arganda C","year":"2025","unstructured":"Arganda C. La AEMPS ya trabaja en los cuatro escenarios de evaluaci\u00f3n posibles en 2025 y 2026. Diariofarma [Internet]. 2025 Jan 13 [cited 2026 Jun 17]. Available from: https:\/\/diariofarma.com\/2025\/01\/13\/la-aemps-ya-trabaja-en-los-cuatro-escenarios-de-evaluacion-posibles-en-2025-y-2026","journal-title":"Diariofarma [Internet]"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2691179","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14737167.2026.2691179","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2691179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:03:27Z","timestamp":1783937007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2026.2691179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7,3]]}},"alternative-id":["10.1080\/14737167.2026.2691179"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2026.2691179","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}